Kayla Barnes-Lentz adopts longevity protocol leading to younger ovarian biological age
Updated
Updated · USA TODAY · Apr 26
Kayla Barnes-Lentz adopts longevity protocol leading to younger ovarian biological age
10 articles · Updated · USA TODAY · Apr 26
At age 35, Barnes-Lentz's ovaries tested biologically 30 using Timeless Biotech’s machine learning-based assessment, following her detailed health regimen in Austin.
Her protocol includes advanced therapies, strict nutrition, and daily routines, with results and methods shared publicly to a large online following, though experts caution against drawing causal conclusions from her personal data.
Barnes-Lentz’s approach highlights gaps in women’s health research and sparks broader conversations on female longevity, while she collaborates with medical professionals and monetizes her expertise through memberships and affiliate links.
With her advising the testing company, how can we trust her 'younger' ovarian age results?
Why did science ignore ovarian health's central role in female longevity for so long?
Is extreme biohacking the future of health or an expensive fantasy for the wealthy?
If the rich can buy extra decades of health, what does that mean for society?
Does obsessively tracking every health metric lead to a longer life or just more anxiety?
Could living in a high-tech wellness bubble create new, unforeseen health risks?